Court filing makes public my previously suppressed analysis of paxil's effects

Ethical Human Psychology and Psychiatry

Volumn 8, Issue 1, 2006, Pages 77-84

  Breggin, Peter R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; IMIPRAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGGRESSIVENESS; AGITATION; AKATHISIA; ANXIETY DISORDER; AUTOMUTILATION; CAUSE OF DEATH; CLINICAL TRIAL; COURT; DRUG EFFECT; DRUG MARKETING; DRUG OVERDOSE; FOOD AND DRUG ADMINISTRATION; HOSTILITY; HUMAN; IRRITABILITY; MANIA; MEDICAL EXPERT; MEDICOLEGAL ASPECT; MENTAL INSTABILITY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SIDE EFFECT; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT;

EID: 33644609185     PISSN: 15594343     EISSN: 19389000     Source Type: Journal    
DOI: 10.1891/ehpp.8.1.77     Document Type: Review

References (5)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision) (DSM-IV-TR). Washington, DC: Author.
2. Breggin, P. (1991). Toxic psychiatry. New York: St. Martin's Press.
3. Breggin, P. (1997). Brain-disabling treatments in psychiatry. New York: Springer Publishing Company.
4. Breggin, P. (2001). The antidepressant fact book. Cambridge, MA: Perseus Books.
5. Breggin, P. R. (2003). Suicidality, violence, and mania caused by selective serotonin reuptake inhibitors: A review and analysis. Ethical Human Sciences and Services, 5, 225-246.